Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement

被引:0
作者
Bor-Sheng Ko
Cheng-Shyong Chang
Ming-Chih Chang
Tsai Yun Chen
Tzeon-Jye Chiou
Chang-Fang Chiu
Wen-Li Huang
Woei-Yau Kao
Yii-Jenq Lan
Shen-Fung Lin
Tran-Der Tan
Jih-Luh Tang
Cheng-Hwai Tzeng
Po-Nan Wang
Su-Pen Yet
Hwei-Fang Tien
机构
[1] National Taiwan University Hospital,Division of Hematology, Department of Internal Medicine
[2] National Health Research Institute,Institute of Systemic and Cellular Medicine
[3] Changhua Christian Hospital,Department of Internal Medicine
[4] Mackay Memorial Hospital,Department of Hematology
[5] Mackay Medical College,Oncology
[6] College of Medicine,Section of Hematology/Oncology, Department of Internal Medicine
[7] National Cheng Kung University,Division of Transfusion Medicine, Department of Medicine
[8] Taipei Veterans General Hospital,Cancer Center
[9] National Yang-Ming University School of Medicine,Department of Medicine
[10] China Medical University Hospital,Division of Hematology/Oncology
[11] School of Medicine,Division of Hematology
[12] China Medical University,Oncology, Department of Internal Medicine
[13] Taichung Veterans General Hospital,Division of Hematology
[14] Buddhist Tzu-Chi General Hospital Taipei Branch,Oncology, Department of Internal Medicine
[15] Chang Gung Memorial Hospital-Keelung,Division of Hematology
[16] Kaohsiung Medical University,Oncology, Department of Internal Medicine
[17] College of Medicine,Department of Internal Medicine
[18] Kaohsiung Medical University,Hematology and Medical Oncology
[19] Koo Foundation Sun Yat-Sen Cancer Center,Division of Hematology/Oncology, Department of Medicine
[20] Taipei Veterans General Hospital,Division of Hematology
[21] National Yang-Ming University School of Medicine,Oncology, Department of Internal Medicine
[22] Chang Gung Memorial Hospital-Linkou,undefined
来源
International Journal of Hematology | 2014年 / 100卷
关键词
Guidelines; Taiwan; MDS; ICT; Iron overload; Ferritin;
D O I
暂无
中图分类号
学科分类号
摘要
Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.
引用
收藏
页码:7 / 15
页数:8
相关论文
共 50 条
[41]   Guidelines for the management of adult myelodysplastic syndromes [J].
Killick, Sally B. ;
Ingram, Wendy ;
Culligan, Dominic ;
Enright, Helen ;
Kell, Jonathan ;
Payne, Elspeth M. ;
Krishnamurthy, Pramila ;
Kulasekararaj, Austin ;
Raghavan, Manoj ;
Stanworth, Simon J. ;
Green, Simone ;
Mufti, Ghulam ;
Quek, Lynn ;
Cargo, Catherine ;
Jones, Gail L. ;
Mills, Juliet ;
Sternberg, Alex ;
Wiseman, Daniel H. ;
Bowen, David .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) :267-281
[42]   Optimizing Therapy for Iron Overload in the Myelodysplastic SyndromesRecent Developments [J].
Heather A. Leitch .
Drugs, 2011, 71 :155-177
[43]   Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes [J].
Greenberg, Peter L. ;
Koller, Charles A. ;
Cabantchik, Z. Ioav ;
Warsi, Ghulam ;
Glynos, Tara ;
Paley, Carole ;
Schiffer, Charles .
LEUKEMIA RESEARCH, 2010, 34 (12) :1560-1565
[44]   Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements [J].
Angel F. Remacha ;
Beatriz Arrizabalaga ;
Consuelo Del Cañizo ;
Guillermo Sanz ;
Ana Villegas .
Annals of Hematology, 2010, 89 :147-154
[45]   Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload [J].
Du, Yali ;
Long, Zhangbiao ;
Chen, Miao ;
Han, Bing ;
Hou, Bo ;
Feng, Feng .
ACTA HAEMATOLOGICA, 2017, 138 (02) :119-128
[46]   Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes [J].
Hu, Jiaxin ;
Meng, Fanqiao ;
Hu, Xian ;
Huang, Lei ;
Liu, Hui ;
Liu, Zhaoyun ;
Li, Lijuanli .
LEUKEMIA RESEARCH, 2020, 93
[47]   Treating high-risk myelodysplastic syndromes [J].
Ades, Lionel .
BULLETIN DU CANCER, 2023, 110 (11) :1162-1167
[48]   Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines [J].
Michael Pfeilstöcker .
memo - Magazine of European Medical Oncology, 2010, 3 (1) :11-15
[49]   Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines [J].
Pfeilstoecker, M. .
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2010, 3 (01) :11-15
[50]   Impact of the International Consensus Classification of myelodysplastic syndromes [J].
Zhang, Yudi ;
Wu, Junying ;
Xu, Zefeng ;
Qin, Tiejun ;
Qu, Shiqiang ;
Pan, Lijuan ;
Wang, Huijun ;
Sun, Qi ;
Li, Chengwen ;
Jia, Yujiao ;
Cai, Wenyu ;
Yan, Xin ;
Gong, Jingye ;
Gao, Qingyan ;
Li, Bing ;
Gale, Robert Peter ;
Xiao, Zhijian .
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (03) :443-448